Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
1 clinical trials · Condition
◉ Watch Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
| Record | Firm | Date |
|---|---|---|
| Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden (NCT04553393) | Chinese PLA General Hospital | 2020-09-09 |
Track Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden automatically
Every clearance here is in the API, with alerts when new ones post.